North Central Cancer Treatment Group researchers based at Mayo Clinic in Rochester, Minn., have discovered that low doses of a drug used to prevent epileptic seizures and to treat nerve pain caused by shingles substantially reduces hot flashes in patients who are undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.
GlaxoSmithKline (NYSE: GSK) announced positive data from three key studies on its first-in-class, oral small molecule HER2 kinase inhibitor, Tykerb (lapatinib).
China has opposed US FDA’s warning on toothpaste from China, and termed this irresponsible act on the part of US FDA, saying low levels of diethylene glycol (DEG) are not harmful.
Januvia (scientific name sitagliptin), a new drug designed to improve blood sugar control in patients with type 2 diabetes, should not be used because the drug?s long-term safety is still unknown, Public Citizen writes in a new June posting on its WorstPills.org Web site.
Massey scientists have discovered a weak link in human digestion that could revolutionise healthy eating and medical treatment for the chronically-ill.
An apple a day keeps the doctor away? Or, what appears to be more accurate: An apple peel a day might help keep cancer at bay, according to a new Cornell study.
University of Florida researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in people at risk for the disease.
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a phase II clinical trial at the University of Texas M. D. Anderson Cancer Center.
The simple notion of copying the body?s own natural “waste disposal” chemistry to mop up potentially toxic nitrogen has saved an estimated 80 percent of patients with urea cycle disorders — most of them children ? according to a report in this week?s New England Journal of Medicine summarizing a quarter century of experience with the treatment.
Flaxseed, an edible seed that is rich in omega 3-fatty acids and fiber-related compounds known as lignans, is effective in halting prostate tumor growth, according to a study led by Duke University Medical Center researchers.